Minimally-invasive approach for rectal cancer surgery

The Lancet Oncology

Volumn 15, Issue 7, 2014, Pages 680-681

  Brouquet, Antoine ^a   Nordlinger, Bernard ^b  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; COLON RESECTION; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPY; LONG TERM SURVIVAL; MINIMALLY INVASIVE SURGERY; MORBIDITY; NOTE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RISK REDUCTION; SAFETY; SURGICAL APPROACH; TREATMENT INDICATION;

CHEMORADIOTHERAPY; FEMALE; HUMANS; LAPAROSCOPY; MALE; RECTAL NEOPLASMS;

EID: 84901638280     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70233-5     Document Type: Note

References (10)

1. MacFarlane JK, Ryall RD, Heald RJ Mesorectal excision for rectal cancer. Lancet 1993, 341:457-460.
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
3. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
4. Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002, 20:817-825.
5. Matthiessen P, Hallböök O, Rutegård J, Simert G, Sjödahl R Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 2007, 246:207-214.
6. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004, 350:2050-2059. Clinical Outcomes of Surgical Therapy Study Group.
7. Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005, 365:1718-1726.
8. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010, 11:637-645.
9. van der Pas MH, Haglind E, Cuesta MA, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013, 14:210-218.
10. Jeong S-Y, Park JW, Nam BH Open versus laparscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 2014, published online May 16. http://dx.doi.org/10.1016/S1470-2045(14)70205-0.